Abstract
Introduction and purpose
Neuronal ceroid lipofuscinoses (NCLs) is a group of congenital metabolic diseases where the neurodegenerative process with the accumulation of ceroid and lipofuscin autofluorescent storage materials is at the forefront. According to the age of presentation, NCLs are classified as congenital, infantile (INCL), late infantile (LINCL), juvenile (JNCL), and adult (ANCL) NCLs. In our study, it was aimed to discuss the clinical and molecular characteristics of our patients diagnosed with NCL.
Material and method
This is a descriptive cross-sectional study which was conducted in 14 patients from 10 unrelated families who were diagnosed with different types of NCL based on clinical presentation, neuroimaging, biochemical measurements, and molecular analyses, at the department of pediatric metabolism between June 2015 and June 2020.
Results
A total of 14 patients were diagnosed with different types of NCL. Of those, 4 patients were diagnosed with NCL7 (4/14; 30%), 3/14 (23%) with NCL1, 3/14 (23%) with NCL2, 2/14 (14.2%) with NCL13, and 1/14 (7.1%) with NCL10. Eleven pathogenic variants were detected, 5 of which are novel (c.721G>T [p.Gly241Ter] and c.301G>C [p.Ala146Pro] in MFDS8 gene; c.316C>T [p.Gln106Ter] in PPT1 gene; c.341C>T [p.Ala114Val] in TPP1 gene; c.686A>T [p.Glu229Val] in CTSD gene)
Conclusion
This study is one of the pioneer comprehensive researches from Turkey that provides information about disease-causing variants and clinical presentation of different and rare types of NCLs. The identification of novel variants and phenotypic expansion is important for genetic counselling in Turkey and expected to improve understanding of NCLs.
Similar content being viewed by others
References
Haltia M, Goebel HH (2013) The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta (BBA) - Mol Basis Dis 1832(11):1795–1800. https://doi.org/10.1016/j.bbadis.2012.08.012
Ren X-T, Wang X-H, Ding C-H, Shen X, Zhang H, Zhang W-H, Li J-W, Ren C-H, Fang F (2019) Next-generation sequencing analysis reveals novel pathogenic variants in four Chinese siblings with late-infantile neuronal ceroid lipofuscinosis. Front Genet 10:370. https://doi.org/10.3389/fgene.2019.00370
Lewis G, Morrill AM, Conway-Allen SL, Kim B (2020) Review of cerliponase alfa: recombinant human enzyme replacement therapy for late-infantile neuronal ceroid lipofuscinosis type 2. J Child Neurol 35(5):348–353. https://doi.org/10.1177/0883073819895694
Schulz A, Kohlschütter A, Mink J, Simonati A, Williams R (2013) NCL diseases—clinical perspectives. Biochim Biophys Acta 1832(11):1801–1806. https://doi.org/10.1016/j.bbadis.2013.04.008
Radke J, Stenzel W, Goebel HH (2015) Human NCL neuropathology. Biochim Biophys Acta (BBA) - Mol Basis Dis 1852(10):2262–2266. https://doi.org/10.1016/j.bbadis.2015.05.007
Williams RE, Mole SE (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79(2):183–191. https://doi.org/10.1212/WNL.0b013e31825f0547
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A (2018) Study of intraventricular cerliponase Alfa for CLN2 disease. N Engl J Med 378(20):1898–1907. https://doi.org/10.1056/NEJMoa1712649
Katz ML, Tecedor L, Chen Y, Williamson BG, Lysenko E, Wininger FA, Young WM, Johnson GC, Whiting REH, Coates JR, Davidson BL (2015) AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Sci Transl Med 7(313):313ra180. https://doi.org/10.1126/scitranslmed.aac6191
Shyng C, Nelvagal HR, Dearborn JT, Tyynelä J, Schmidt RE, Sands MS, Cooper JD (2017) Synergistic effects of treating the spinal cord and brain in CLN1 disease. Proc Natl Acad Sci U S A 114(29):E5920–E5929. https://doi.org/10.1073/pnas.1701832114
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Topçu M, Tan H, Yalnýzoðlu D, Usubütün A, Saatçi I, Aynacý M, Anlar B, Topaloðlu H, Turanlý G, Köse G, Aysun S (2004) Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: Clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr 46(1):103
Cardona F, Rosati E (1995) Neuronal ceroid-lipofuscinoses in Italy: an epidemiological study. Am J Med Genet 57(2):142–143. https://doi.org/10.1002/ajmg.1320570206
Claussen M, Heim P, Knispel J, Goebel HH, Kohlschütter A (1992) Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet 42(4):536–538. https://doi.org/10.1002/ajmg.1320420422
Uvebrant P, Hagberg B (1997) Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics 28(1):6–8. https://doi.org/10.1055/s-2007-973654
Kirveskari E, Partinen M, Santavuori P (2001) Sleep and its disturbance in a variant form of late infantile neuronal ceroid lipofuscinosis (CLN5). J Child Neurol 16(10):707–713. https://doi.org/10.1177/088307380101601001
Maganti R, Hausman N, Koehn M, Sandok E, Glurich I, Mukesh BN (2006) Excessive daytime sleepiness and sleep complaints among children with epilepsy. Epilepsy Beha 8(1):272–277. https://doi.org/10.1016/j.yebeh.2005.11.002
Heikkilä E, Hàtònen TH, Telakivi T, Laakso ML, Heiskala H, Salmi T, Alila A, Santavuori P (1995) Circadian rhythm studies in neuronal ceroid-lipofuscinosis (NCL). Am J Med Genet 57(2):229–234. https://doi.org/10.1002/ajmg.1320570223
Lehwald LM, Pappa R, Steward S, de los Reyes, E. (2016) Neuronal ceroid lipofuscinosis and associated sleep abnormalities. Pediatr Neurol 59:30–35. https://doi.org/10.1016/j.pediatrneurol.2016.02.009
Vanhanen SL, Raininko R, Autti T, Santavuori P (1995) MRI evaluation of the brain in infantile neuronal ceroid-lipofuscinosis. Part 2: MRI findings in 21 patients. J Child Neurol 10(6):444–450. https://doi.org/10.1177/088307389501000604
Aungaroon G, Hallinan B, Jain P, Horn PS, Spaeth C, Arya R (2016) Correlation among genotype, phenotype, and histology in neuronal ceroid lipofuscinoses: an individual patient data meta-analysis. Pediatr Neurol 60:42–48.e4. https://doi.org/10.1016/j.pediatrneurol.2016.03.018
Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Kleine Holthaus S-M, McKay TR, Medina DL, Rahim AA, Schulz A, Smith AJ (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18(1):107–116. https://doi.org/10.1016/S1474-4422(18)30368-5
Smith KR, Dahl H-HM, Canafoglia L, Andermann E, Damiano J, Morbin M, Bruni AC, Giaccone G, Cossette P, Saftig P, Grötzinger J, Schwake M, Andermann F, Staropoli JF, Sims KB, Mole SE, Franceschetti S, Alexander NA, Cooper JD et al (2013) Cathepsin F mutations cause type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 22(7):1417–1423. https://doi.org/10.1093/hmg/dds558
Bras J, Djaldetti R, Alves AM, Mead S, Darwent L, Lleo A, Molinuevo JL, Blesa R, Singleton A, Hardy J, Clarimon J, Guerreiro R (2016) Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer’s disease identifies a homozygous CTSF mutation. Neurobiol Aging 46:236.e1–236.e6. https://doi.org/10.1016/j.neurobiolaging.2016.06.018
Wang C, Xu H, Yuan Y, Lian Y, Xie N, Ming L (2018) Novel compound heterozygous mutations causing Kufs disease type B. Int J Neurosci 128(6):573–576. https://doi.org/10.1080/00207454.2017.1403439
Doccini S, Sartori S, Maeser S, Pezzini F, Rossato S, Moro F, Toldo I, Przybylski M, Santorelli FM, Simonati A (2016) Early infantile neuronal ceroid lipofuscinosis (CLN10 disease) associated with a novel mutation in CTSD. J Neurol 263(5):1029–1032. https://doi.org/10.1007/s00415-016-8111-6
Fritchie K, Siintola E, Armao D, Lehesjoki A-E, Marino T, Powell C, Tennison M, Booker JM, Koch S, Partanen S, Suzuki K, Tyynelä J, Thorne LB (2009) Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 117(2):201–208. https://doi.org/10.1007/s00401-008-0426-7
Varvagiannis K, Hanquinet S, Billieux M, De Luca R, Rimensberger P, Lidgren M, Guipponi M, Makrythanasis P, Blouin J, Antonarakis S, Steinfeld R, Kern I, Poretti A, Fluss J, Fokstuen S (2018) Congenital neuronal ceroid lipofuscinosis with a novel ctsd gene mutation: a rare cause of neonatal-onset neurodegenerative disorder. Neuropediatrics 49(02):150–153. https://doi.org/10.1055/s-0037-1613681
Author information
Authors and Affiliations
Contributions
All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Corresponding author
Ethics declarations
Competing interests
The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Ethical statement informed consent
Informed consent was obtained from the parents of all patients included in this paper.
Ethical approval
The research related to human use complied with all the relevant regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board or equivalent committee.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kose, M., Kose, E., Ünalp, A. et al. Neuronal ceroid lipofuscinosis: genetic and phenotypic spectrum of 14 patients from Turkey. Neurol Sci 42, 1103–1111 (2021). https://doi.org/10.1007/s10072-021-05067-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05067-8